Australia markets open in 2 hours 24 minutes

iRhythm Technologies, Inc. (IRTC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
101.70+3.40 (+3.46%)
As of 03:35PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close98.30
Open98.30
Bid101.22 x 800
Ask101.81 x 800
Day's range96.52 - 101.74
52-week range85.74 - 169.54
Volume222,824
Avg. volume359,696
Market cap3.062B
Beta (5Y monthly)1.44
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    iRhythm Technologies Shares Preliminary Fourth Quarter 2022 Highlights and Business Update at the 41st Annual J.P. Morgan Healthcare Conference

    SAN FRANCISCO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced preliminary fourth quarter operational highlights and a business update at the 41st Annual J.P. Morgan Healthcare Conference. Preliminary Fourth Quarter 2022 Operational Highlights Patient registration growth of more than 20% compared to the fourth quarter 2021Sequential im

  • GlobeNewswire

    iRhythm® Technologies to Present at the 41st Annual J.P. Morgan Healthcare Conference

    SAN FRANCISCO, Dec. 27, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference. iRhythm’s management is scheduled to present on Tuesday, January 10, 2023, at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. Interested parties may access a live and archived we

  • GlobeNewswire

    Results of Four Studies Demonstrating Clinical, Economic Value of iRhythm’s Product Portfolio Presented at American Heart Association ’22

    Clinical studies presented at the American Heart Association 2022 Scientific Sessions event demonstrate compelling diagnostic and health economic value of the Zio® suite of products across a range of clinical applicationsSAN FRANCISCO, Nov. 07, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading cardiovascular diagnostics and digital healthcare solutions company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the results o